Klaus Lubke

Title: Klaus Lubke: Innovator in Radioactively Labeled Steroid Derivatives

Introduction

Klaus Lubke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of diagnostic agents. His innovative work has led to the creation of a patent that showcases his expertise in steroid derivatives.

Latest Patents

Klaus Lubke holds a patent for "Radioactively labeled steroid derivatives." This patent involves steroids that bear the substituent --X-NR.sub.1 R.sub.2, where --NR.sub.1 R.sub.2 is a tritium or carbon-14 labeled amino or amino-acid group. The substituent --X-- can be --R.sub.3 --, --OCOR.sub.3 --, =N--O--R.sub.3 --, or --NHCOR.sub.3 --, with R.sub.3 being --(CH.sub.2).sub.n CO--, where n ranges from 0 to 4. These compounds are particularly useful as diagnostic agents, highlighting their potential in medical applications. Klaus Lubke has 1 patent to his name.

Career Highlights

Klaus Lubke has had a distinguished career, working with Schering Aktiengesellschaft, a prominent pharmaceutical company. His role at Schering has allowed him to focus on innovative research and development in the field of steroid derivatives. His contributions have been instrumental in advancing the understanding and application of radioactively labeled compounds in diagnostics.

Collaborations

Throughout his career, Klaus has collaborated with notable colleagues, including Otto Engelfried and Bob Nieuweboer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Klaus Lubke's work in the field of radioactively labeled steroid derivatives exemplifies his commitment to advancing medical diagnostics. His patent and collaborations reflect his significant impact on the pharmaceutical industry. His contributions continue to influence the development of diagnostic agents, showcasing the importance of innovation in healthcare.